Onyvax Company

Onyvax develops cancer therapies that harness the selective power of the immune system to seek out and destroy tumor cells.
Technology: Whole-Cell Antigens
Industry: Whole-Cell Antigens
Headquarters: Bradford, Somerset, United Kingdom
Founded Date: 1997-01-01
Employees Number: 11-50
Funding Status: Late Stage Venture
Investors Number: 5
Total Funding: 29800000
Last Funding Date: 2006-05-08
Last Funding Type: Series C

Visit Website
Register and Claim Ownership